Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis(1)

BACKGROUND: Pharmacological treatment of Alzheimer’s disease (AD) involves symptomatic improvement of cognition using cholinesterase inhibitors (ChEIs) and memantine. The cost-effectiveness of these medications will guide decision-makers in making judicious use of scarce healthcare resources, partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yunusa, Ismaeel, Alsahali, Saud, Rane, Amey, Eguale, Tewodros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543376/
https://www.ncbi.nlm.nih.gov/pubmed/34755044
http://dx.doi.org/10.3233/ADR-210307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543376/
https://www.ncbi.nlm.nih.gov/pubmed/34755044
http://dx.doi.org/10.3233/ADR-210307

Ejemplares similares